Fomepizole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01213 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sclerosing cholangitis | KG + DL |
| 2 | pulmonary hypertension | KG + DL |
| 3 | kyphoscoliotic heart disease | KG + DL |
| 4 | rheumatoid arthritis | KG + DL |
| 5 | infectious otitis media | KG + DL |
| 6 | middle ear cholesterol granuloma | KG + DL |
| 7 | facial nerve palsy due to herpes zoster infection | KG + DL |
| 8 | otosalpingitis | KG + DL |
| 9 | middle ear disease | KG + DL |
| 10 | gout | KG + DL |
| 11 | allergic otitis media | KG + DL |
| 12 | non-suppurative otitis media | KG + DL |
| 13 | chronic otitis media | KG + DL |
| 14 | suppurative otitis media | KG + DL |
| 15 | Smouldering systemic mastocytosis | KG + DL |
| 16 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 17 | brachydactyly-syndactyly syndrome | KG + DL |
| 18 | systemic mastocytosis | KG + DL |
| 19 | Lyme disease | KG + DL |
| 20 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 21 | suppurative cholangitis | KG + DL |
| 22 | IgG4-related sclerosing cholangitis | KG + DL |
| 23 | multiple endocrine neoplasia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.